Hybrid Molecule from Farnesylthiosalicylic Acid-Diamine and Phenylpropenoic Acid As Ras-related Signaling Inhibitor with Potent Antitumor Activities.

Yong Ling,Zhiqiang Wang,Xuemin Wang,Xianghua Li,Xinyang Wang,Wei Zhang,Hong Dai,Li Chen,Yihua Zhang
DOI: https://doi.org/10.1111/cbdd.12393
2014-01-01
Chemical Biology & Drug Design
Abstract:Novel series of Farnesylthiosalicylic acid-diamine/phenylpropenoic acid hybrids were designed and synthesized. Their in vitro growth inhibitory assays showed that most compounds displayed strong antiproliferation activity against seven cancer cells. Especially, the new hybrid 12 f, by the conjugation of 10a with ferulic acid, could selectively suppress the proliferation of tumor cells and display significantly lower toxicities to normal cells than its intermediate 10a. Furthermore, 12 f dose-dependently induced SMMC-7721 cell apoptosis. Additionally, our observations demonstrated that 12 f inhibited both Ras-related signaling and phosphorylated NF-κB synergistically, which may be advantageous to the strong antitumor activities of 12 f. Our findings suggest that these novel hybrids may hold a great promise as therapeutic agents for the intervention of human cancers.
What problem does this paper attempt to address?